Hoth Therapeutics

Quarterly Financials

Values in thousands 2025-06-30 2025-03-31 2024-12-31 2024-09-30
Revenue
$0
$0
$0
$0
Gross Profit
-4
EBITDA
-2,199
-3,476
-2,383
-2,132
EBIT
-3,480
Net Income
-2,199
-3,475
-2,382
-2,132
Net Change In Cash
0
0
0
0
Free Cash Flow
-2,372
-2,788
-2,028
-1,634
Cash
9,014
11,317
7,038
8,022
Basic Shares
13,180
127
7,290
6,903

Annual Financials

Values in thousands 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-66
-46,871
EBITDA
-8,188
-153
-10,678
-14,313
EBIT
-16,403
-7,845
-21,744
-14,101
Net Income
-8,188
-7,845
-11,371
-14,313
Net Change In Cash
0
0
0
0
Free Cash Flow
-6,978
-8,447
-9,371
-12,207
Cash
7,038
9,292
6,428
8,538
Basic Shares
6,375
3,409
1,197
893

Earnings Calls

Quarter EPS
2025-06-30
-$0.17
2025-03-31
-$0.27
2024-12-31
-$0.32
2024-09-30
-$0.31